par Lambert, Catherine;Dubois, Bénédicte;Dive, Dominique;Lysandropoulos, Andreas ;Selleslag, Dominik;Vanopdenbosch, Ludo;Van Pesch, Vincent;Vanwijmeersch, Bart;Janssens, Ann
Référence Acta neurologica belgica, 118, 1, page (7-11)
Publication Publié, 2018-03
Référence Acta neurologica belgica, 118, 1, page (7-11)
Publication Publié, 2018-03
Article révisé par les pairs
Résumé : | The article Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus, written by Lambert et al., was originally published electronically on the publisher’s internet portal on 27 January 2018 without open access. With the author(s)' decision to opt for Open Choice the copyright of the article changed on March 3, 2018 to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The original article has been corrected. |